{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-041710","form_type":"8-K","ticker":"BBLG","cik":"0001419554","company_name":"Bone Biologics Corp","filed_at":"2024-10-21T23:59:59+00:00","discovered_at":"2026-05-14T18:03:08.403203+00:00","generated_at":"2026-05-30T12:19:31.058509+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"Bone Biologics appoints Phillip Meikle to board, replacing retiring director Don Hankey","bullets":["Phillip Meikle appointed to Bone Biologics board effective October 16, 2024.","Meikle founded Biosystems of New England (sold to Stryker in 2019), 30+ years orthopedic/spine experience.","Don R. Hankey retired from board after seven years of service; board size stays at four.","Meikle will be compensated in the same manner as other Bone Biologics directors.","No arrangements or transactions requiring disclosure under Item 404(a) were identified."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-041710","json":"https://secwatch.observer/filing/0001493152-24-041710.json","markdown":"https://secwatch.observer/filing/0001493152-24-041710.md","text":"https://secwatch.observer/filing/0001493152-24-041710.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1419554/000149315224041710/0001493152-24-041710-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1419554/000149315224041710/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T12:19:31.058509+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"08fd3dbf80","claim":"Phillip Meikle was appointed as Director at Bone Biologics Corp.","evidence_excerpt":"On October 16, 2024, the Board of Directors (the “Board”) of Bone Biologics Corporation (the “Company”) appointed Phillip Meikle to the Company’s Board.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1419554/000149315224041710/0001493152-24-041710-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}